Senior living provider The Pennant Group (NASDAQ: PNTG) met Wall Street’s revenue expectations in Q3 2026, with sales up 32.1% year on year to $300.4 million. Its non-GAAP profit of $0.35 per share was in line with analysts’ consensus estimates.

Is now the time to buy PNTG? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

The Pennant Group’s latest quarter met Wall Street’s expectations for both revenue and non-GAAP profit, but the market reacted negatively, likely reflecting concerns around margin pressure and operational disruptions. Management attributed the quarter’s results to higher employee benefits costs and short-term challenges in integrating newly acquired senior living communities, particularly in two concentrated markets. CEO Brent Guerisoli called these cost pressures “higher-than-anticipated,” noting their impact on earnings. Leadership acknowledged that, despite positive growth in patient and resident volumes, these elevated expenses created a drag on profitability.

Looking forward, Pennant’s management sees opportunity for long-term growth but remains cautious about short-term volatility. The company plans to focus on optimizing recent acquisitions and managing benefit expenses, with CFO Lynette Walbom stating elevated benefit costs will persist into the next quarter. President John Gochnour emphasized ongoing investments in local leadership and payer relations as key levers, while also highlighting the potential for improved managed care rates as Pennant demonstrates its quality metrics. Management reaffirmed annual guidance but cautioned that integration-related disruptions and cost variability could affect near-term results.

Key insights from management’s remarks

Pennant’s quarter was driven by rapid patient and resident growth, but integration and benefits costs weighed on profitability and led management to highlight the need for operational stability.

• Home health and hospice expansion: The company saw nearly 40% more home health patients and 35% more hospice patients year over year, driven by both organic growth and the integration of 75 new locations over two years. This rapid expansion required significant investment in leadership development and infrastructure support to ensure quality and consistency.
• Senior living acquisition challenges: The addition of 16 senior living communities since last year—seven in the recent quarter—created short-term operational hurdles. Management cited two specific markets where leadership resources were stretched thin, resulting in lower-than-expected performance and a dip in occupancy for same-store locations.
• Elevated employee benefit costs: Higher-than-anticipated employee benefits expenses affected all segments. CFO Lynette Walbom quantified the impact as a 50 basis point drag on revenue in the quarter, expecting similar effects in the next quarter. These costs were not confined to newly acquired businesses but were broad-based across the company.
• Regulatory changes in home health: The release of the Home Health Final Rule brought a modest 2.1% net payment rate increase, which management considered insufficient to offset inflation and rising costs. The rule also added new program integrity measures, increasing compliance burdens for legitimate providers like Pennant.
• Leadership pipeline investment: Over 100 CEOs-in-training were added this year, aiming to strengthen local operating capacity and support ongoing growth. Management pointed to this leadership bench as critical for stabilizing and optimizing newly acquired and existing operations during periods of rapid expansion.

Drivers of future performance

Pennant’s outlook focuses on stabilizing recent acquisitions, controlling benefit costs, and leveraging payer partnerships to support revenue and margin goals.

• Integration and operational optimization: Management sees the completion of key integration milestones for acquired home health and senior living sites as essential for future performance. President John Gochnour described ongoing efforts to stabilize occupancy in newly acquired senior living communities and optimize the Southeast home health agencies, targeting a return to expected financial and clinical benchmarks over the next several quarters.
• Managing employee benefit expense: Elevated benefit costs are expected to persist into the next quarter, with CFO Lynette Walbom highlighting that this pressure is built into current forecasts. The company is working on strategies to more predictably manage these expenses but acknowledged ongoing volatility as a risk to margins in the near term.
• Payer strategy and market positioning: Pennant is prioritizing negotiations with managed care payers, aiming to leverage its strong clinical outcomes and national coverage to secure better rates, particularly in newly integrated Southeast markets. Management believes narrowing payer networks and the company’s quality metrics present an opportunity for improved reimbursement and long-term growth.

Catalysts in upcoming quarters

In upcoming quarters, the StockStory team will watch (1) whether Pennant can stabilize occupancy and operational performance in newly acquired senior living communities, (2) if integration of Southeast home health agencies translates to improved margins and volume growth, and (3) the company’s progress in controlling benefit cost inflation. We will also track developments in managed care negotiations and regulatory impacts on reimbursement.

The Pennant Group currently trades at $36.70, down from $44.04 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

Stocks that trumped tariffs

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.